Evidence map›Paper›PMID 33195735›Full record

ArticleOncoscience2020

Fragile site instability: measuring more than breaks.

Irina Waisertreiger, Jacqueline Barlow

Open access · diamondAbstract read
In one paragraph

Article in Oncoscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Irina WaisertreigerDepartment of Microbiology and Molecular Genetics, University of California, Davis, CA, USA.
Jacqueline BarlowDepartment of Microbiology and Molecular Genetics & Genome Center, University of California, Davis, CA, USA.
University of California, Davis · US

Funding

The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in NeuroblastomaK08CA194162 · NCI · EMORY UNIVERSITY · PI SCHNEPP, ROBERT WALTER · 2016 to 2020
$841k
Characterization of replication-mediated DNA damage in B lymphocytesK22CA188106 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BARLOW, JACQUELINE · 2015 to 2017
$486k
NCI NIH HHS K08 CA194162NCI NIH HHS K22 CA188106
6 · The paper itself

Abstract

Genome instability is not only a hallmark of cancer, it is necessary for its initiation and evolution, and naturally accumulates as cells age. Replication stress is a potent source of genome instability found in many tumor types [1]. Chromosomal fragile sites are genomic loci highly prone to DNA damage specifically from replication stress and are frequently mutated in cancer [2-4]2-4]. While tracking the origin of individual mutations has proved challenging, measuring DNA damage and repair at endogenous sites can offer key insights into understanding the etiology of cancer. In the past 15 years, the causal link between replication stress, oncogene activation, and tumor initiation and evolution has become increasingly clear [1, 5-9]. Replication-associated damage accumulates at early stages of tumorigenesis and may promote further transformation. Studying the causes and consequences of fragile site instability can offer a window into the earliest stages of carcinogenesis [10-13]. In particular, fragile site studies will help us understand the molecular underpinnings influencing the frequency of DNA breakage, successful repair processes suppressing genome instability, and unsuccessful repair leading to mutations and chromosome rearrangements. Of these, measuring successful repair is the most challenging as it leaves little evidence behind.

Indexed as

common fragile siteDNA damage replication stressearly replicating fragile sitefluorescent hybridization in situgenome instabilityhomologous recombination repairsister chromatid exchanges

Identifiers

PMID33195735
PMCPMC7640903
OpenAlexW3099763264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.